Sarepta shares soar on FDA voting questions

The FDA added a voting question to the agenda for the Monday meeting of the Peripheral and Central Nervous System Drugs Advisory Committee.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.